The pharmaceutical industry continuously seeks innovative molecules to combat challenging diseases, with cancer therapy being a prominent area of focus. High-purity chemical intermediates are indispensable for synthesizing potential drug candidates. 7-Methylquinazolin-4(3H)-one, a key heterocyclic building block, plays a significant role in the development of promising anticancer agents. NINGBO INNO PHARMCHEM CO.,LTD. is a leading provider of this critical intermediate, supporting research and development globally.

Understanding 7-Methylquinazolin-4(3H)-one in Synthesis

7-Methylquinazolin-4(3H)-one, identified by CAS number 75844-40-5, is a foundational molecule in organic chemistry, particularly within medicinal chemistry. Its structure lends itself to the synthesis of various quinazolinone derivatives, which are known for their diverse biological activities. The scientific literature details robust methods for its preparation, emphasizing the need for high purity and efficient yields. As a reliable manufacturer and supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures its 7-Methylquinazolin-4(3H)-one product meets stringent quality standards, exceeding 98% purity. This makes it an ideal starting material for pharmaceutical research, and we offer competitive pricing for bulk purchases from our base in China.

Anticancer Properties of Quinazolinone Derivatives

The importance of 7-Methylquinazolin-4(3H)-one is most evident in the potent anticancer activities observed in its synthesized derivatives. Research has consistently shown that these compounds can exhibit significant in vitro cytotoxic effects against various cancer cell lines, such as HepG2 and MCF-7. The efficacy of these derivatives, often on par with or superior to established drugs like doxorubicin, highlights their therapeutic potential. For pharmaceutical companies and research institutions, securing high-quality intermediates from trusted manufacturers is crucial for successful drug discovery and development. This includes the ability to buy these compounds reliably and cost-effectively.

Computational Tools for Drug Discovery Enhancement

To further understand and optimize the action of these anticancer agents, computational methods, including molecular docking, are widely utilized. These simulations help predict how synthesized quinazolinone derivatives interact with key biological targets, such as enzymes like thymidylate synthase and dihydrofolate reductase, which are vital for cancer cell survival and proliferation. Such in-silico analyses are invaluable for refining molecular design and identifying lead compounds. They provide critical data for researchers deciding which chemical intermediates to purchase for their projects.

Your Source for High-Quality Pharmaceutical Intermediates

NINGBO INNO PHARMCHEM CO.,LTD. is committed to advancing pharmaceutical innovation by providing essential chemical intermediates like 7-Methylquinazolin-4(3H)-one. We pride ourselves on being a reliable supplier with a strong focus on quality and customer service. We invite researchers, chemists, and procurement specialists to contact us to discuss their specific needs, inquire about bulk orders, and explore how our high-purity compounds can contribute to the successful development of next-generation anticancer therapies.